The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Abstract
Toll-like receptors (TLRs) are a family of innate immune-recognition receptors that recognize molecular patterns associated with microbial pathogens, and induce antimicrobial immune responses. Double-stranded RNA (dsRNA) is a molecular pattern associated with viral infection, because it is produced by most viruses at some point during their replication. Here we show that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-kappaB and the production of type I interferons (IFNs). TLR3-deficient (TLR3-/-) mice showed reduced responses to polyinosine-polycytidylic acid (poly(I:C)), resistance to the lethal effect of poly(I:C) when sensitized with d-galactosamine (d-GalN), and reduced production of inflammatory cytokines. MyD88 is an adaptor protein that is shared by all the known TLRs. When activated by poly(I:C), TLR3 induces cytokine production through a signalling pathway dependent on MyD88. Moreover, poly(I:C) can induce activation of NF-kappaB and mitogen-activated protein (MAP) kinases independently of MyD88, and cause dendritic cells to mature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, several RNA structural features have been described as immunostimulatory due to interactions with various RNA sensors such as Toll-like receptors, RIG-I, and PKR.”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [7]
In the citing paper
“Activation of TLR3 signaling by its agonists can induce apoptosis in human cancer cells [29, 33].”
From Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells (2016) · cites this paper as [33]
In the citing paper
“Through recognition of TLR3 in endosomes or retinoic acid-inducible gene I, melanoma differentiation-associated protein 5, and inflammasomes in the cytoplasm,96, 97, 98, 99 depending on the amount, dsRNAs might overactivate innate immunity and lead to adverse events.”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [96]
In the citing paper
“90.7% efficacy in participants 5 to 11 years of age96”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [96]
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,741
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,680
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,605
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Unresponsiveness of MyD88-deficient mice to endotoxin.
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,367
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C.-Q., Ghosh, S., & Janeway, C. (1998) · Molecules and Cells · doi:10.1016/s1097-2765(00)80136-7 · Cited by 1,783
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,052
Influenza-virus-induced signaling cascades: targets for antiviral therapy?
Ludwig, S., Planz, O., Pleschka, S., & Wolff, T. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00010-2 · Cited by 170
Terenzi, F., Hui, D. J., Merrick, W. C., & Sen, G. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605771200 · Cited by 177
Nod2: The intestinal gate keeper
Nabhani, Z. A., Dietrich, G., Hugot, J., & Barreau, F. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006177 · Cited by 178
Innate immune receptors in platelets and platelet-leukocyte interactions
Dib, P. R. B., Quirino-Teixeira, A. C., Merij, L. B., Pinheiro, M. B. M., Rozini, S. V., Andrade, F. B., & Hottz, E. D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0620-701r · Cited by 174
Parker, L. C., Prince, L. R., & Sabroe, I. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03203.x · Cited by 172
Effects of viral respiratory infections on lung development and childhood asthma
Gern, J. E., Rosenthal, L. A., Sorkness, R. L., & Lemanske, R. F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.057 · Cited by 169
Sato, S. (2002) · International Immunology · doi:10.1093/intimm/dxf046 · Cited by 167
Breiman, A., Grandvaux, N., Lin, R., Ottone, C., Akira, S., Yoneyama, M., Fujita, T., Hiscott, J. B., & MEURS, E. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.3969-3978.2005 · Cited by 168
Sauder, D. N. (2003) · British Journal of Dermatology · doi:10.1046/j.0366-077x.2003.05628.x · Cited by 174
Hepatitis A virus: Host interactions, molecular epidemiology and evolution
Vaughan, G., Rossi, L. M. G., Forbi, J. C., de Paula, V. S., Purdy, M. A., Xia, G., & Khudyakov, Y. E. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.10.023 · Cited by 174
Signatures of positive selection in Toll-like receptor (TLR) genes in mammals
Areal, H., Abrantes, J., & Esteves, P. J. (2011) · BMC Evolutionary Biology · doi:10.1186/1471-2148-11-368 · Cited by 167
How important are Toll‐like receptors for antimicrobial responses?
Carpenter, S., & O'Neill, L. A. J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00965.x · Cited by 182
A Novel Toll-like Receptor That Recognizes Vesicular Stomatitis Virus
Shi, Z., Cai, Z., Sanchez, A., Zhang, T., Wen, S., Wang, J., Yang, J., Fu, S., & Zhang, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159590 · Cited by 166
Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response
Swanson, C. L., Wilson, T. J., Strauch, P., Colonna, M., Pelanda, R., & Torres, R. M. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092695 · Cited by 162
Biology of Toll receptors: lessons from insects and mammals
Imler, J., & Zheng, L. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403160 · Cited by 173
Double-stranded RNAs from the Helminth Parasite Schistosoma Activate TLR3 in Dendritic Cells
Aksoy, E., Zouain, C. S., Vanhoutte, F., Fontaine, J., Pavelka, N., Thiéblemont, N., Willems, F., Ricciardi‐Castagnoli, P., Goldman, M., Capron, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411223200 · Cited by 166
Sanford, J. A., Zhang, L.-J., Williams, M. R., Gangoiti, J. A., Huang, C.-M., & Gallo, R. L. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah4609 · Cited by 166
Lartigue, A., Courville, P., Auquit, I., François, A., Arnoult, C., Tron, F., Gilbert, D., & Musette, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1349 · Cited by 165
Intracellular Pathogen Detection by RIG-I-Like Receptors
Dixit, E., & Kagan, J. C. (2013) · Advances in immunology · doi:10.1016/b978-0-12-410524-9.00004-9 · Cited by 172
Neerincx, A., Lautz, K., Menning, M., Kremmer, E., Zigrino, P., Hösel, M., Büning, H., Schwarzenbacher, R., & Kufer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109736 · Cited by 164
Koerner, J., Horvath, D. J., Herrmann, V. L., MacKerracher, A., Gander, B. A., Yagita∥, H., Rohayem, J., & Groettrup, M. (2021) · Nature Communications · doi:10.1038/s41467-021-23244-3 · Cited by 169
Anthony, D. D., Yonkers, N. L., Post, A. B., Asaad, R. J., Heinzel, F. P., Lederman, M. M., Lehmann, P., & Valdez, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4907 · Cited by 165
Determinants of interferon-stimulated gene induction by RNAi vectors
Kaeser-Pebernard, S., & Iggo, R. D. (2004) · Differentiation · doi:10.1111/j.1432-0436.2004.07202001.x · Cited by 165
Principles of intracellular viral recognition
Saito, T., & Gale, M. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.11.003 · Cited by 166
Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses
Zhang, S., Jouanguy, E., Sancho‐Shimizu, V., von Bernuth, H., Yang, K., Abel, L., Pïcard, C., Puel, A., & Casanova, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00564.x · Cited by 171
Akira, S., & Hoshino, K. (2003) · The Journal of Infectious Diseases · doi:10.1086/374749 · Cited by 170
Toll-like receptors in the depressed and suicide brain
Pandey, G. N., Rizavi, H. S., Ren, X., Bhaumik, R., & Dwivedi, Y. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.01.021 · Cited by 164
Horiguchi, H., Loftus, T. J., Hawkins, R. B., Raymond, S. L., Stortz, J. A., Hollen, M. K., Weiss, B. P., Miller, E. S., Bihorac, A., Larson, S. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00595 · Cited by 164
Toll-like receptor expression in normal ovary and ovarian tumors
Zhou, M., McFarland-Mancini, M. M., Funk, H. M., Husseinzadeh, N., Mounajjed, T., & Drew, A. F. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0650-y · Cited by 164
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8
Estornes, Y., Toscano, F., Virard, F., Jacquemin, G., Pierrot, A., Vanbervliet, B., Bonnin, M., Lalaoui, N., Mercier‐Gouy, P., Pachéco, Y., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.22 · Cited by 164
Rožková, D., Horváth, R., Bartůňková, J., & Špíšek, R. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.04.567 · Cited by 164
Direct Costimulatory Effect of TLR3 Ligand Poly(I:C) on Human γδ T Lymphocytes
Wesch, D., Beetz, S., Oberg, H., Marget, M., Krengel, K., & Kabelitz, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1348 · Cited by 168
Jégo, G., Bataille, R., Geffroy-Luseau, A., Descamps, G., & Pellat‐Deceunynck, C. (2006) · Leukemia · doi:10.1038/sj.leu.2404226 · Cited by 163
Yan, S. R., Qing, G., Byers, D. M., Stadnyk, A. W., Al‐Hertani, W., & Bortolussi, R. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1223-1229.2004 · Cited by 163
Extracellular miRNA: A Collision of Two Paradigms
Turchinovich, A. A., Tonevitsky, A., & Burwinkel, B. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.08.004 · Cited by 168
TLR7: A new sensor of viral infection
Crozat, K., & Beutler, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401347101 · Cited by 163
RNA:DNA hybrids are a novel molecular pattern sensed by TLR9
Rigby, R. E., Webb, L. M., Mackenzie, K. J., Li, Y., Leitch, A., Reijns, M. A. M., Lundie, R. J., Revuelta, A., Davidson, D. J., Diebold, S. S., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386117 · Cited by 169
Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutions
Ballarín-González, B., & Howard, K. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.004 · Cited by 164
Hui, C. W., St-Pierre, A., Hajj, H. E., Remy, Y., Hébert, S. S., Luheshi, G. N., Srivastava, L. K., & Tremblay, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00013 · Cited by 166
Toll-Like Receptors and Their Function in Innate and Adaptive Immunity
Heine, H., & Lien, E. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000069517 · Cited by 162
X-ray crystal structure of IRF-3 and its functional implications
Takahasi, K., Suzuki, N. N., Horiuchi, M., Mori, M., Suhara, W., Okabe, Y., Fukuhara, Y., Terasawa, H., Akira, S., Fujita, T., et al. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb1001 · Cited by 162
MDA5 and MAVS Mediate Type I Interferon Responses to Coxsackie B Virus
Wang, J. P., Cerny, A., Asher, D. R., Kurt‐Jones, E. A., Bronson, R. T., & Finberg, R. W. (2009) · Journal of Virology · doi:10.1128/jvi.00631-09 · Cited by 161
New paradigms in inflammatory signaling in vascular endothelial cells
Xiao, L., Liu, Y., & Wang, N. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00182.2013 · Cited by 166
Way, S. S., Thompson, L. J., Lopes, J. E., Hajjar, A. M., Kollmann, T. R., Freitag, N. E., & Wilson, C. B. (2004) · Cellular Microbiology · doi:10.1046/j.1462-5822.2004.00360.x · Cited by 161
Modulation of Toll?interleukin 1 receptor mediated signaling
Li, X., & Qin, J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0622-4 · Cited by 159
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
Christensen, S. R., & Shlomchik, M. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.005 · Cited by 159
Mifsud, E. J., Tan, A. C. L., & Jackson, D. C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00079 · Cited by 163
Paone, A., Starace, D., Galli, R., Padula, F., De Cesaris, P., Filippini, A., Ziparo, E., & Riccioli, A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn149 · Cited by 160
From periphery to center stage: 50 years of advancements in innate immunity
Carpenter, S. B., & O'Neill, L. A. J. (2024) · Cell · doi:10.1016/j.cell.2024.03.036 · Cited by 171
Host defense function of the airway epithelium in health and disease: clinical background
Message, S. D., & Johnston, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703315 · Cited by 159
Sun, B., Robertsen, B., Wang, Z., & Liu, B. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.10.001 · Cited by 161
Peterhans, E., Jungi, T. W., & Schweizer, M. (2003) · Biologicals · doi:10.1016/s1045-1056(03)00024-1 · Cited by 158
Triantafilou, M., Morath, S., Mackie, A. R., Härtung, T., & Triantafilou, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01270 · Cited by 158
Viral Determinants of Resistance to Treatment in Patients with Hepatitis C
Wohnsland, A., Hofmann, W. P., & Sarrazin, C. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-06 · Cited by 158
Ibeagha-Awemu, E. M., Lee, J., Ibeagha, A. E., Bannerman, D. D., Paape, M. J., & Zhao, X. (2007) · Veterinary Research · doi:10.1051/vetres:2007047 · Cited by 158
Natural type I interferon-producing cells as a link between innate and adaptive immunity
Kadowaki, N., & Liu, Y.-J. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00751-6 · Cited by 164
Novel functions of proteins encoded by viral stress-inducible genes
Sarkar, S. N., & Sen, G. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.007 · Cited by 160
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Schellack, C., Prinz, K., Egyed, A., Fritz, J. H., Wittmann, B., Ginzler, M., Swatosch, G., Zauner, W., Kast, C. E., Akira, S., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.071 · Cited by 158
Danger‐associated molecular patterns ( DAMPs ) in acute lung injury
Tolle, L. B., & Standiford, T. J. (2013) · The Journal of Pathology · doi:10.1002/path.4124 · Cited by 157
No Love Lost Between Viruses and Interferons
Fensterl, V., Chattopadhyay, S., & Sen, G. C. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055249 · Cited by 167
Rasschaert, J., Ladrière, L., Urbain, M., Doğusan, Z., Katabua, B., Sato, S., Akira, S., Gysemans, C. A., Mathieu, C., & Eizirik, D. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502213200 · Cited by 157
Nucleic acid-binding polymers as anti-inflammatory agents
Lee, J., Sohn, J. W., Zhang, Y., Leong, K. W., Pisetsky, D. S., & Sullenger, B. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105777108 · Cited by 155
Role of Extracellular RNA and TLR3‐Trif Signaling in Myocardial Ischemia–Reperfusion Injury
Chen, C., Feng, Y., Zou, L., Wang, L. L., Chen, H. H., Cai, J., Xu, J., Sosnovik, D. E., & Chao, W. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000683 · Cited by 157
Ohto, U., Ishida, H., Shibata, T., Sato, R., Miyake, K., & Shimizu, T. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.013 · Cited by 159
SIKE is an IKKε/TBK1‐associated suppressor of TLR3‐ and virus‐triggered IRF‐3 activation pathways
Huang, J., Liu, T., Xu, L., Chen, D., Zhai, Z., & Shu, H. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600863 · Cited by 155
Rock, K. L., Hearn, A. R., Chen, C., & Shi, Y. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0173-3 · Cited by 158
The role of Toll-like receptor 2 in microbial disease and immunity
Wetzler, L. M. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00201-9 · Cited by 157
Park, C., Lee, S., Cho, I., Lee, H. K., Kim, D., Choi, S., Oh, S. B., Park, K., Kim, J. S., & Lee, S. J. (2005) · Glia · doi:10.1002/glia.20278 · Cited by 159
Signalling of Toll-Like Receptors
Brikos, C., & O'Neill, L. A. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_2 · Cited by 157
Weiss, G., Rasmussen, S., Zeuthen, L., Nielsen, B. N., Jarmer, H. Ø., Jespersen, L., & Frøkiær, H. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03301.x · Cited by 156
Nucleotide Sequences and Modifications That Determine RIG-I/RNA Binding and Signaling Activities
Uzri, D., & Gehrke, L. (2009) · Journal of Virology · doi:10.1128/jvi.02449-08 · Cited by 155
Molecular and Cellular Basis of Microflora-Host Interactions1,
Winkler, P., Ghadimi, D., Schrezenmeir, J., & Kraehenbühl, J.-P. (2007) · Journal of Nutrition · doi:10.1093/jn/137.3.756s · Cited by 158
Mucosal vaccine delivery: Current state and a pediatric perspective
Shakya, A. K., Chowdhury, M. Y. E., Tao, W., & Gill, H. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.014 · Cited by 158
Song, H., Huang, P., Niu, J., Shi, G., Zhang, C., Kong, D., & Wang, W. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.004 · Cited by 158
Qin, F., Xia, F., Chen, H., Cui, B., Feng, Y., Zhang, P., Chen, J., & Luo, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.633776 · Cited by 167
Gribar, S. C., Richardson, W. M., Sodhi, C. P., & Hackam, D. J. (2008) · Molecular Medicine · doi:10.2119/2008-00035.gribar · Cited by 156
Lundberg, A. M., Drexler, S. K., Monaco, C. G., Williams, L. M., Sacre, S. M., Feldmann, M., & Foxwell, B. M. J. (2007) · Blood · doi:10.1182/blood-2007-02-072934 · Cited by 155
Role of Toll‐like receptors in costimulating cytotoxic T cell responses
Schwarz, K., Storni, T., Manolova, V., Didierlaurent, A. M., Sirard, J., Röthlisberger, P., & Bachmann, M. F. (2003) · European Journal of Immunology · doi:10.1002/eji.200323919 · Cited by 155
Proud, D., Sanders, S. P., & Wiehler, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4637 · Cited by 154
Vacchelli, E., Eggermont, A. M. M., Sautès‐Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.25238 · Cited by 160
Ranjith-Kumar, C. T., Miller, W. R., Sun, J., Xiong, J., Santos, J., Yarbrough, I., Lamb, R. J., Mills, J. K., Duffy, K. E., Hoose, S. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700209200 · Cited by 154
Novel Role of Toll-Like Receptor 3 in Hepatitis C-Associated Glomerulonephritis
Wörnle, M., Schmid, H., Banas, B., Merkle, M., Henger, A., von Roeder, M., Blattner, S. M., Bock, E., Kretzler, M., Gröne, H., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050491 · Cited by 152
MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease
Bolz, D. D., Sundsbak, R. S., Ma, Y., Akira, S., Kirschning, C. J., Zachary, J. F., Weis, J. H., & Weis, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2003 · Cited by 155
Adaptor usage and Toll‐like receptor signaling specificity
Dunne, A., & O'Neill, L. A. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.024 · Cited by 155
Li, H., Zhang, J., Kumar, A., Zheng, M., Atherton, S. S., & Yu, F. X. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02275.x · Cited by 156
Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?
O'Neill, L. A. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02222-6 · Cited by 154
Hippenstiel, S., Opitz, B., Schmeck, B., & Suttorp, N. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-97 · Cited by 158
Bourquin, C., Anz, D., Zwiorek, K., Lanz, A.-L., Fuchs, S. P., Weigel, S., Wurzenberger, C., von der Borch, P., Golić, M., Moder, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2990 · Cited by 152
Wound Healing Is Impaired in MyD88-Deficient Mice
Macedo, L., Pinhal‐Enfield, G., Alshits, V., Elson, G., Cronstein, B. N., & Leibovich, S. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061048 · Cited by 158
Interferon and cytokine responses to SARS-coronavirus infection
Thiel, V., & Weber, F. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.001 · Cited by 150
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 162
Jiang, W., Sun, R., Wei, H., & Tian, Z. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504570102 · Cited by 153
Pascolo, S. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1285 · Cited by 152
Antiviral immunity in crustaceans
Liu, H., Söderhäll, K., & Jiravanichpaisal, P. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.02.009 · Cited by 152
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
Toussi, D. N., & Massari, P. (2014) · Vaccines · doi:10.3390/vaccines2020323 · Cited by 161
Innate immune cell populations function as initiators and effectors in Th2 cytokine responses
Saenz, S. A., Noti, M., & Artis, D. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.09.001 · Cited by 152
Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood
Wit, D. D., Tonon, S., Olislagers, V., Goriely, S., Boutriaux, M., Goldman, M., & Willems, F. (2003) · Journal of Autoimmunity · doi:10.1016/j.jaut.2003.08.003 · Cited by 152
Mutz, P., Metz, P., Lempp, F. A., Bender, S., Qu, B., Schöneweis, K., Seitz, S., Tu, T., Restuccia, A., Frankish, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.044 · Cited by 152
Distinct changes in endosomal composition promote NLRP3 inflammasome activation
Zhang, Z., Venditti, R., Li, R., Liu, Z., Vivot, K., Schürmann, A., Bonifacino, J. S., Matteis, M. A. D., & Ricci, R. (2022) · Nature Immunology · doi:10.1038/s41590-022-01355-3 · Cited by 155
Expression of functional Toll-like receptor 2 on human epidermal keratinocytes
Kawai, K., Shimura, H., Minagawa, M., Ito, A., Tomiyama, K., & Ito, M. (2002) · Journal of Dermatological Science · doi:10.1016/s0923-1811(02)00105-6 · Cited by 154
Metadata
- Authors
- Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A.
- Affiliations
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Medzhitov, Ruslan
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2001-10
- Volume
- 413
- Issue
- 6857
- Pages
- 732-738
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2076361525
- Cited by
- 6,129
- References
- 30
- Citations by year
- 2026: 134 · 2025: 156 · 2024: 161 · 2023: 174 · 2022: 203 · 2021: 270 · 2020: 216 · 2019: 203 · 2018: 209 · 2017: 209 · 2016: 219 · 2015: 237 · 2014: 258 · 2013: 279 · 2012: 303
- FWCI
- 66.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TLR3, double-stranded RNA, NF-κB activation, type I interferon, MyD88, poly(I:C), innate immunity, viral infection, MAPK signaling, dendritic cell maturation, inflammatory cytokines
- MeSH terms
- Amino Acid Sequence, Animals, Antigens, Differentiation, B-Lymphocytes, Cell Line, Cells, Cultured, Galactosamine, Humans, Interferon Type I, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Molecular Sequence Data, Poly I-C, Receptors, Cell Surface, Receptors, Immunologic, RNA, Double-Stranded, Virus Diseases, Signal Transduction, Cytokines, NF-kappa B, Sequence Homology, Amino Acid, Mitogen-Activated Protein Kinases, Drosophila Proteins, Adaptor Proteins, Signal Transducing, Toll-Like Receptors, Toll-Like Receptor 3, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review